It is a known fact that COX2 inhibitor treatment leads to a significant reduction in the number of colorectal polyps in patients with familial adenomatous polyposis (Steinbach et al, 2000; Higuchi et al, 2003). This evidence concerns the gene PTGS2 and Familial adenomatous polyposis.